CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome

Syed Shahid Habib1, Mohammad Ibrahim Kurdi, Zohair Al Aseri

  • 1Department of Physiology, College of Medicine & KKUH, King Saud University, Riyadh. shahidhabib44@hotmail.com

Insights

Peak high-sensitivity C-reactive protein (hsCRP) levels are higher in ST-elevation myocardial infarction (STEMI) patients compared to non-ST-elevation myocardial infarction (NSTEMI) patients. This suggests inflammation plays a role in myocardial infarction and hsCRP may aid risk stratification.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation

Background:

  • High-sensitivity C-reactive protein (hsCRP) is of significant interest for cardiovascular risk assessment.
  • Elevated hsCRP early in acute coronary syndrome (ACS) may indicate underlying cardiovascular comorbidities.
  • hsCRP's role in differentiating myocardial infarction subtypes requires further investigation.

Purpose of the Study:

  • To investigate serial hsCRP measurements in acute coronary syndrome (ACS) patients.
  • To compare hsCRP levels between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) patients.

Main Methods:

  • An observational study involving 89 patients with acute myocardial infarction (AMI).
  • Three serial hsCRP measurements were taken: baseline (admission), peak (36-48 hours), and follow-up (4-6 weeks).
  • hsCRP levels were compared between STEMI and NSTEMI patient groups.

Main Results:

  • STEMI patients exhibited higher Body Mass Index (BMI), Creatine Kinase-Myocardial Bound (CKMB), and Aspartate Aminotransferase (AST) levels compared to NSTEMI patients.
  • Baseline and follow-up hsCRP levels did not significantly differ between STEMI and NSTEMI groups.
  • Peak hsCRP levels were significantly higher in STEMI patients than in NSTEMI patients (p=0.0464).

Conclusions:

  • STEMI patients demonstrate significantly elevated peak hsCRP levels compared to NSTEMI patients.
  • These findings support the independent role of inflammation in myocardial infarction pathogenesis.
  • hsCRP assessment may be a valuable tool for risk stratification post-myocardial infarction.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...